Insmed Inc.是一家全球性生物制药公司，专注于为存在高度未满足医疗需求的严重罕见病患者开发、商业化创新疗法，核心布局肺部、内分泌类罕见病治疗赛道，服务覆盖北美、欧洲及亚太地区的患者群体。
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
营收
$264.0M
净利润
$30.8M
ACAD
ACADIA PHARMACEUTICALS INC
$284.0M
$273.6M
IDYA
IDEAYA Biosciences, Inc.
$207.8M
$119.2M
BBSI
BARRETT BUSINESS SERVICES INC
$321.1M
$16.4M
RARE
Ultragenyx Pharmaceutical Inc.
$207.3M
$-128.6M
MDGL
MADRIGAL PHARMACEUTICALS, INC.
$-58.6M
HL
HECLA MINING CO
$448.1M
$134.4M
IONS
IONIS PHARMACEUTICALS INC
$203.3M
$-229.4M
